The notch ligands Jagged1 and 2 are a potential therapeutic target in multiple myeloma- associated bone disease

M. Colombo(Human Technopole), Raffaella Chiaramonte(University of Milan), Alfonso Neri, S. Garavelli(University of Milan), Alessandro Paoli(University of Milan), S. Galletti, Natalia Platonova(University of Milan), Katia Todoerti(Fondazione IRCCS Istituto Nazionale dei Tumori)
Unknown
June 1, 2015
Cited by 0

Related Papers

Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells
|Biochemical Pharmacology|2007|118
Senescence-Dependent Regulation of Type 1 Plasminogen Activator Inhibitor in Human Vascular Endothelial Cells
|Experimental Cell Research|1995|110
High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor
|BMC Cancer|2013|110
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
|Leukemia|2019|109
Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes
|Leukemia|2013|84